🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This will be the first time GSK1325756 Solution for Infusion formulation th...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-06-12
Trial ID
NCT02169583
Danirixin (DNX) is a selective CXC chemokine receptor (CXCR2) antagonist be...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-04-25
Trial ID
NCT03034967
Treatments Being Tested
The aim of this First Time in Patient study is to obtain initial informatio...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-13
Trial ID
NCT02130193
Danirixin (DNX) is a novel, selective, and reversible antagonist of the C-X...
Status
Terminated
Location
GSK Investigational Site
Start Date
2017-01-19
Trial ID
NCT02927431
Treatments Being Tested
Danirixin is a selective chemokine receptor antagonist being developed as a...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-05-10
Trial ID
NCT03136380
Treatments Being Tested
Study 201682 is a Phase IIa, randomized, double blind, placebo-controlled f...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-06-01
Trial ID
NCT02469298
This study will invite two groups of volunteers to participate. The data f...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-11-05
Trial ID
NCT01267006
Treatments Being Tested